©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10658-10667
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10658
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10658
Table 1 Direct and indirect clinical effects of cytomegalovirus in transplant recipients
| Direct clinical effects | Indirect clinical effects |
| CMV syndrome | Acute allograft rejection |
| Fever > 38 °C for 2/4 d | Chronic allograft rejection |
| Malaise | Allograft failure |
| Myelosuppression | Vanishing duct syndrome/ductopenia |
| Tissue-invasive CMV disease1 Gastrointestinal disease (entire gastrointestinal tract can be affected) | Allograft hepatitis and fibrosis |
| Vascular thrombosis | |
| Opportunistic and other infections | |
| Hepatitis | Fungal (Aspergillus, Pneumocystis) |
| Pneumonitis | Bacterial (Nocardia) |
| Retinitis | Viral (HHV-6, HHV-7, EBV) |
| CNS disease | Hepatitis C virus recurrence |
| Carditis | EBV associated PTLD |
| Mortality | Mortality |
- Citation: Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World J Gastroenterol 2014; 20(31): 10658-10667
- URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10658.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10658